Model
Edge
EyePoint Pharmaceuticals Inc.
0002013623
Filing Type
144
Filing Date
1/4/2026
Updated
1/5/26, 2:42 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities